Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Forbedring af hypertensionskontrol i sikkerhedsnet-indstillinger: Boston Hypertension Equity Alliance i behandling (BHEAT)

27. september 2026 opdateret af: Boston Medical Center

Sammenlignende effektivitet af interventioner til forbedring af hypertensionskontrol i sikkerhedsnet-indstillinger: Boston Hypertension Equity Alliance i behandling

High blood pressure (BP) or hypertension (HTN) affects over 100 million individuals in the US, increasing the risk of adverse outcomes, including stroke, myocardial infarction (MI), and chronic kidney disease (CKD). Effective therapies include non-pharmacologic approaches and multiple medication classes. Successful HTN management requires ongoing patient engagement for BP monitoring and treatment intensification. Reaching this goal is challenging, and many patients with HTN do not have controlled BP.

Using a collaborative partnership between patients, clinicians, health system and public health stakeholders, and the research team the investigators plan to overcome barriers to widespread implementation of evidence-based health system strategies to improve BP control in a large, urban, primary care-based safety-net setting for diverse populations experiencing disparities in HTN-related outcomes.

Studieoversigt

Status

Rekruttering

Intervention / Behandling

Detaljeret beskrivelse

A hybrid type 1 effectiveness-implementation study will be implemented to evaluate the comparative impact of each intervention on clinical outcomes while also assessing implementation at each site. The multi-site cluster randomized stepped-wedge design allows for feasible resource allocation and sequential roll out of the interventions for comparison, ensuring each site has the opportunity to benefit from both approaches. Data will be collected for multiple patient reported outcomes (PROs) to understand the range of impacts of the interventions from the patient perspective.

The specific aims are to:

  • Assess comparative effectiveness of remote BP monitoring (RBPM) versus RBPM + multilevel intensification intervention (MII) on HTN control and quality of care. Prior research has demonstrated the effectiveness of each of these interventions yet the optimal approach to achieve equity in HTN control in safety net practices remains unknown.
  • Use mixed methods, guided by the Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) framework, to assess implementation of the two comparators as measured by reach, adoption, implementation (fidelity) and maintenance. Using a convergent parallel design, the investigators will use concurrent quantitative and qualitative data to obtain perspectives across multiple levels to understand the reasons for success or failure of implementation of each comparator. By merging these data, integration can be achieved by using qualitative themes related to implementation to support or refute quantitative findings of reach and fidelity.
  • Evaluate the comparative impacts of each intervention on PROs assessed with validated measures of patient activation, medication adherence, and trust in medical settings. The study intervention approaches were informed by direct feedback from the targeted diverse patients and clinical providers to address patient-reported barriers to HTN control: lack of activation, adherence to medications, and trust in their care providers.

Undersøgelsestype

Interventionel

Tilmelding (Anslået)

16895

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiekontakt

Undersøgelse Kontakt Backup

Studiesteder

    • Massachusetts
      • Boston, Massachusetts, Forenede Stater, 02118
        • Rekruttering
        • Boston Healthcare for the Homeless (BHCHP)
      • Boston, Massachusetts, Forenede Stater, 02118
        • Rekruttering
        • Boston Medical Center Family Medicine
      • Boston, Massachusetts, Forenede Stater, 02118
        • Rekruttering
        • Boston Medical Center, General Internal Medicine primary care
      • Boston, Massachusetts, Forenede Stater, 02118
        • Rekruttering
        • Neighborhood Health
      • Boston, Massachusetts, Forenede Stater, 02126
        • Rekruttering
        • Mattapan Community Health Center
      • Quincy, Massachusetts, Forenede Stater, 02169
        • Rekruttering
        • Manet Community Health Center
      • Roslindale, Massachusetts, Forenede Stater, 02131
        • Rekruttering
        • Greater Roslindale Medical and Dental Center (GRMDC)

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år og ældre (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion Criteria:

  • Adult (age>18) patients receiving primary care at one of the 9 participating sites, with primary care provider (PCP) visit in the preceding year
  • Presence of HTN defined by one or more of: 1) diagnosis included on active problem list, 2) active HTN medications in prior year, 3) 3 separate elevated BP measurements
  • Uncontrolled HTN defined as systolic blood pressure (SBP)>140

Exclusion Criteria:

  • Not meeting the inclusion criteria

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Sundhedstjenesteforskning
  • Tildeling: Randomiseret
  • Interventionel model: Sekventiel tildeling
  • Maskning: Ingen (Åben etiket)

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: Remote Blood Pressure Monitoring (RBPM)

Individual level interventions fo monitor blood pressure.

Standardized blood pressure measurement and treatment protocols in clinical practice.

Eksperimentel: Multilevel Intensification interventions (MII)

Team-based interventions to mitigate clinical inertia which is the lack of intensification of treatment despite inadequate disease control such as for HTN.

Standardized blood pressure measurement and treatment protocols in clinical practice.

Team-based interventions including multiple evidence-proven interventions such as clinician decision support, monitoring medication non-adherence, use of combination pills, and formulary modifications.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Systolic blood pressure (SBP) improvement
Tidsramme: Baseline, every 3 months up to 54 months

Change in BP abstracted from the electronic health record (EHR).

Baseline, every 3 months up to 54 months
Interventions received
Tidsramme: Baseline, 54 months

The number and proportion of individuals who receive each intervention.

Baseline, 54 months
Patient activation
Tidsramme: Baseline, 18 months, 30 months, 36 months, 42 months, 54 months

Patient activation will be assessed with the Consumer Health Activation index (CHAI), a 10 item validated instrument that generates a score of 0-100, with ≥80 indicating moderate/high activation.

Baseline, 18 months, 30 months, 36 months, 42 months, 54 months

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Blood pressure control
Tidsramme: Baseline, 18 months, 30 months, 36 months, 42 months, 54 months

Assessed as Yes/No from EHR records for Systolic BP<140 mmHg and Systolic BP<130 mmHg.

Baseline, 18 months, 30 months, 36 months, 42 months, 54 months
Medication intensification
Tidsramme: Baseline, 18 months, 30 months, 36 months, 42 months, 54 months

Assessed from EHR and claims data.

Baseline, 18 months, 30 months, 36 months, 42 months, 54 months
BP monitoring
Tidsramme: Baseline, 18 months, 30 months, 36 months, 42 months, 54 months

Assessed by EHR data on the frequency of BP monitoring.

Baseline, 18 months, 30 months, 36 months, 42 months, 54 months
Fidelity of interventions
Tidsramme: Baseline, 18 months, 30 months, 36 months, 42 months, 54 months

The number and proportion of individuals who receive all key elements of the interventions based on EHR data.

Baseline, 18 months, 30 months, 36 months, 42 months, 54 months
Medication adherence
Tidsramme: Baseline, 18 months, 30 months, 36 months, 42 months, 54 months

the 3-item self-report scale by Wilson will be used to assess this outcome. It queries patients about how many days they missed medications and overall consistency over the last 30 days. This measure has been standardized to a 0-100 scale, with good adherence defined as ≥80.

Baseline, 18 months, 30 months, 36 months, 42 months, 54 months
Trust in primary care
Tidsramme: Baseline, 18 months, 30 months, 36 months, 42 months, 54 months

Assessed with the 10 item Wake Forest Physician Trust Scale. The scale uses a 5-point Likert scale [1=strongly disagree to 5=strongly agree]. Total scores can range from 10 to 50, and higher scores represent greater trust.

Baseline, 18 months, 30 months, 36 months, 42 months, 54 months

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

8. september 2025

Primær færdiggørelse (Anslået)

1. september 2029

Studieafslutning (Anslået)

1. september 2029

Datoer for studieregistrering

Først indsendt

15. april 2025

Først indsendt, der opfyldte QC-kriterier

21. april 2025

Først opslået (Faktiske)

29. april 2025

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

30. september 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

27. september 2026

Sidst verificeret

1. september 2026

Mere information

Begreber relateret til denne undersøgelse

Yderligere relevante MeSH-vilkår

Andre undersøgelses-id-numre

  • H-45398
  • HMC-2023C2-33345 (Andet bevillings-/finansieringsnummer: Patient-Centered Outcomes Research Institute (PCORI))

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner